[adam_arthur]

Healthcare stocks tend to be a “risk off” trade, so I wouldn’t be surprised if the sell off was primarily driven by fund managers rotating risk off to risk on (given the hopes driven by CPI yesterday)

But I was also struck by how insanely overvalued Eli Lilly has become. PE of 53, and the PE multiple has expanded 3x over the last two years, while the underlying business has been mostly flat

[naijaboiler]

GLP-1??

[adam_arthur]

Could be some drug in the pipeline. If anybody is aware please comment

But it’s already a 330B company, hard to imagine a single drug moving them that much